Validation of lab instruments and quantitative test methods Mostafa Mahmoud
This lecture shows the procedures applied when going to validate your laboratory instruments and quantitative test methods also either FDA approved or laboratory developed tests.
Drug-excipient compatibility studies are important to identify compatible excipients for drug formulations. Compatibility can be tested using various analytical techniques including thermal methods like DSC and DTA, accelerated stability studies, spectroscopy like FTIR, and chromatography like TLC. Incompatibilities are identified by changes in thermal behavior, degradation of the drug, or appearance of new peaks in analytical tests. Common techniques involve storing drug-excipient mixtures under accelerated conditions and monitoring the samples for physical or chemical changes over time. The results of compatibility studies provide critical information for formulation development and regulatory filings.
This document outlines the documentation requirements for laboratories to be compliant with ISO/IEC-17025:2017. It lists the key clauses of the standard and whether each technical requirement is procedures (P), documented (R) or implemented (O). Some of the main requirements covered include having documented procedures for impartiality, confidentiality, handling complaints and nonconforming work. Laboratories must also document their organizational structure, personnel requirements, equipment management and methods validation. Technical records must contain sufficient information to enable repetition of tests and monitoring is required to ensure validity of results.
Analytical methods validation as per ich & uspGANESH NIGADE
This document discusses analytical method validation as per ICH and USP guidelines. It defines validation as establishing documentary evidence that a procedure maintains compliance. Method validation involves demonstrating that an analytical procedure is suitable for its intended purpose by testing parameters such as accuracy, precision, specificity, detection limit, quantitation limit, linearity, range, ruggedness and robustness. It also discusses the different types of analytical procedures that require validation including identification tests, quantitative impurity tests, limit tests and assays.
The peroxide value is a measure of the amount of peroxide in a substance, expressed in milliequivalents of active oxygen per 1000 grams of the substance. The procedure involves accurately weighing 5 grams of the substance, dissolving it in a mixture of acetic acid and chloroform, then titrating it with sodium thio sulfate solution and measuring the amount needed to reach the endpoint. The peroxide value is then calculated based on the titration results and the weight of the substance. Autoxidation and rancidity can occur when oxygen is absorbed by oils, leading to oxidation and degradation over time.
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...Ms. Pooja Bhandare
PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-III Classification and mode of action of disinfectants. DISINFECTANT
Definition: Ideal properties of disinfectants: CLASSIFICATION OF DISINFECTANTS: Based on consistency 1. Liquid (E.g., Alcohols, Phenols) 2.Gaseous (Formaldehyde vapor, Ethylene oxide). Based on spectrum of activity 1. High level disinfectant
2. Intermediate level disinfectant
3. Low level disinfectant .Based on mechanism of action: 1.Action on membrane2.Denaturation of cellular proteins 3.Damage to nucleic acids 4.Oxidation of essential sulfhydryl groups of enzymes 5.Alkylation of amino-, carboxyl- and hydroxyl group. MODE OF ACTION AND APPICATION OF DISINFECTANT
Acid and alkalies
Halogens
Heavy metals
Phenols and its derivatives
Alcohol
Aldehydes
Dyes:
Quaternary ammonium compounds
Detergents and soaps.
Carbohydrates || Food Analysis || Pharmaceutical Analysis Department || M.Pha...saimuniswetha1
Hello everyone,
Today's topic Carbohydrates in Food Analysis subject in M.pharmacy(Pharmaceutical Analysis Department) ..Don't forget to see.. please watch it... If you need explanation about Carbohydrates please click below link : https://youtu.be/aI5UnNYgufY
This document discusses semisolid dosage forms including ointments, creams, and gels. It defines these forms, describes common ingredients used in their preparation such as bases, preservatives, and gelling agents. Methods of preparation including fusion and emulsification are outlined. The document also discusses ideal properties and how these forms are evaluated based on parameters like penetration, release of active ingredients, and irritation potential.
Analytical method validation, ICH Q2 guidelineAbhishek Soni
Analytical Method Validation, ICH Q2 Guideline.
General principles related to the analytical method validation.
Validation of analytical method as per International Council for Harmonisation(ICH) guidelines and the United States Pharmacopeia(USP).
Glossary.
Useful in understanding the terms :
Specificity
Linearity
Range
Accuracy
Precision
Detection limit
Quantitation limit
Robustness
Ruggedness
System suitability testing
Analytical method validation as per ich and usp shreyas B R
Analytical method validation is a process of documenting/ proving that an analytical method provides analytical data acceptable for the intended use.After the development of an analytical procedure, it is must important to assure that the procedure will consistently produce the intended a precise result with high degree of accuracy. The method should give a specific result that may not be affected by external matters. This creates a requirement to validate the analytical procedures. The validation procedures consists of some characteristics parameters that makes the method acceptable with addition of statistical tools.
The document provides details on qualification and validation procedures for gas chromatography (GC) and Fourier transform infrared spectroscopy (FTIR) systems used in pharmaceutical analysis. It describes calibration tests for both instruments, including tests to check wave number precision and reproducibility, linearity, and temperature accuracy and stability. Validation tests are also outlined, such as resolution checks and tests to evaluate performance against acceptance criteria over time as specified in guidance documents. The document provides a thorough overview of qualification processes for critical analytical instruments.
Validation of pharaceutical water system and pure steamJp Prakash
This document discusses the validation of pharmaceutical water systems and pure steam. It covers the validation sequences of design qualification, installation qualification, operational qualification, and performance qualification. Design qualification involves validating components like piping, tanks, filters, and distillation stills. Installation qualification ensures proper installation. Performance qualification demonstrates the system can reliably produce water and steam meeting quality requirements over extended use. Validation is necessary to assure safety, efficacy and quality according to regulations.
Qualification of laboratory equipments by Mayuri SoniMayuri Soni
The document provides standard operating procedures (SOPs) for qualifying common laboratory equipment used for quality control testing of pharmaceuticals. It describes calibration procedures for hardness testers, friability test apparatus, tap density apparatus, disintegration testers, and dissolution test apparatus. The SOPs outline how to test that the equipment meets specifications for factors like force measurements, rotation speeds, temperature control, and oscillations. Regular calibration is necessary to confirm equipment is functioning properly and producing accurate results.
This document discusses validation in the pharmaceutical industry. It begins by defining validation as establishing evidence that a process maintains compliance. It then discusses why validation is important, including that regulatory agencies require validation to ensure consistent, reproducible results. It outlines the types of validation including equipment, facilities, analytical methods, and more. It focuses on analytical method validation, discussing parameters like accuracy, precision, specificity, and more. It emphasizes that validation is necessary to confirm analytical procedures consistently produce the intended results.
This document discusses cleaning validation, which provides documented evidence that approved cleaning procedures will produce equipment suitable for processing pharmaceutical products. It defines different levels of cleaning validation based on risk. Key aspects covered include cleaning techniques, establishing acceptance criteria, sampling methods, analytical methods, and documentation requirements. The goal of cleaning validation is to achieve an appropriate level of cleanliness to avoid contamination between product batches.
This presentation includes detail about cleaning levels,equipments for cleaning validation , steps for cleaning method validation and analytical method validation used for cleaning.
This document discusses various concepts related to analytical method validation including accuracy, precision, specificity, detection limit, and quantitation limit. It provides definitions and recommendations for determining each concept. For accuracy, it recommends assessing using spiked samples or an independent procedure and reporting as percent recovery. For precision, it recommends determining repeatability using 9 determinations at 3 concentrations and reporting as standard deviation and coefficient of variation. Detection limit can be determined visually, by signal-to-noise ratio, or by standard deviation of the blank. Quantitation limit is the lowest concentration that can be quantified and can also be determined visually or by signal-to-noise ratio.
The document provides an overview of the qualification process for high performance liquid chromatography (HPLC) equipment, including design qualification (DQ), installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). It describes the objectives and procedures for each qualification step. Key aspects covered include verifying design specifications, proper installation, operational requirements such as precision, accuracy and noise levels, and ongoing performance monitoring. The goal of qualification is to ensure analytical systems are suitable for their intended use and generate reliable results.
This document discusses analytical method validation. It provides definitions and guidelines for validating analytical methods from regulatory agencies. Key aspects of method validation discussed include accuracy, precision, specificity, range, linearity, limits of detection and quantification. Validation parameters are described for different types of analytical tests including identification, quantitative impurity tests and assays. Guidelines are provided for qualifying analytical instrumentation and categorizing instruments based on complexity.
The document discusses analytical method validation, including defining method validation as ensuring an analytical method provides acceptable data for its intended use. It outlines the common steps in method development and validation and the validation parameters that should be assessed, including accuracy, precision, specificity, linearity, range, and robustness. The document provides details on how each of these parameters should be evaluated during the validation process.
QUALIFICATION OF MANUFACTURING EQUIPMENTSANKUSH JADHAV
it gives the information about qualification of various manufacturing equipment which is used into the pharmaceutical labs. (only for information purpose)
Validation is defined as establishing documented evidence that a process will consistently produce results meeting pre-determined specifications. Key aspects of analytical method validation include accuracy, precision, specificity, limit of detection/quantitation, linearity, range, robustness, and system suitability. Validation demonstrates a method is suitable for its intended use and ensures consistent, reliable results are obtained in compliance with regulations.
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR Dr. Ravi Sankar
This document discusses analytical method validation. It begins with an introduction that defines validation and discusses its importance and regulatory requirements. The document then covers specific validation parameters such as specificity, linearity, accuracy, precision, limit of detection, limit of quantification and more. For each parameter, the document provides definitions, procedures for evaluation, and acceptance criteria. It emphasizes that validation demonstrates a method is suitable for its intended purpose and supports the identity, quality, purity and potency of drug substances and products. The overall summary is that analytical method validation is critical to ensure quality and compliance in the pharmaceutical industry.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
The document discusses the development and validation of an LC-MS/MS bioanalytical method for the determination of a drug in human plasma. It describes the objectives, which are to develop a specific, reliable and cost-effective method. It outlines the key steps in method development including literature search, reference standard preparation, extraction procedure selection, and optimization of separation and detection. The validation parameters that will be evaluated are also summarized, including specificity, accuracy, precision, recovery, matrix effects and stability.
analytical method validation and validation of hplcvenkatesh thota
The document summarizes a seminar on analytical method validation and validation of HPLC. It discusses parameters for method validation according to USP, BP, and ICH guidelines such as accuracy, precision, linearity, range, specificity, detection limit, and quantitation limit. It also covers validation of typical HPLC systems through qualification, design, installation, operational, and performance qualification. Key parameters evaluated during HPLC method validation are discussed, including system suitability tests involving retention factor, relative retention, theoretical plates, resolution, and tailing factor.
Analytical method validation, ICH Q2 guidelineAbhishek Soni
Analytical Method Validation, ICH Q2 Guideline.
General principles related to the analytical method validation.
Validation of analytical method as per International Council for Harmonisation(ICH) guidelines and the United States Pharmacopeia(USP).
Glossary.
Useful in understanding the terms :
Specificity
Linearity
Range
Accuracy
Precision
Detection limit
Quantitation limit
Robustness
Ruggedness
System suitability testing
Analytical method validation as per ich and usp shreyas B R
Analytical method validation is a process of documenting/ proving that an analytical method provides analytical data acceptable for the intended use.After the development of an analytical procedure, it is must important to assure that the procedure will consistently produce the intended a precise result with high degree of accuracy. The method should give a specific result that may not be affected by external matters. This creates a requirement to validate the analytical procedures. The validation procedures consists of some characteristics parameters that makes the method acceptable with addition of statistical tools.
The document provides details on qualification and validation procedures for gas chromatography (GC) and Fourier transform infrared spectroscopy (FTIR) systems used in pharmaceutical analysis. It describes calibration tests for both instruments, including tests to check wave number precision and reproducibility, linearity, and temperature accuracy and stability. Validation tests are also outlined, such as resolution checks and tests to evaluate performance against acceptance criteria over time as specified in guidance documents. The document provides a thorough overview of qualification processes for critical analytical instruments.
Validation of pharaceutical water system and pure steamJp Prakash
This document discusses the validation of pharmaceutical water systems and pure steam. It covers the validation sequences of design qualification, installation qualification, operational qualification, and performance qualification. Design qualification involves validating components like piping, tanks, filters, and distillation stills. Installation qualification ensures proper installation. Performance qualification demonstrates the system can reliably produce water and steam meeting quality requirements over extended use. Validation is necessary to assure safety, efficacy and quality according to regulations.
Qualification of laboratory equipments by Mayuri SoniMayuri Soni
The document provides standard operating procedures (SOPs) for qualifying common laboratory equipment used for quality control testing of pharmaceuticals. It describes calibration procedures for hardness testers, friability test apparatus, tap density apparatus, disintegration testers, and dissolution test apparatus. The SOPs outline how to test that the equipment meets specifications for factors like force measurements, rotation speeds, temperature control, and oscillations. Regular calibration is necessary to confirm equipment is functioning properly and producing accurate results.
This document discusses validation in the pharmaceutical industry. It begins by defining validation as establishing evidence that a process maintains compliance. It then discusses why validation is important, including that regulatory agencies require validation to ensure consistent, reproducible results. It outlines the types of validation including equipment, facilities, analytical methods, and more. It focuses on analytical method validation, discussing parameters like accuracy, precision, specificity, and more. It emphasizes that validation is necessary to confirm analytical procedures consistently produce the intended results.
This document discusses cleaning validation, which provides documented evidence that approved cleaning procedures will produce equipment suitable for processing pharmaceutical products. It defines different levels of cleaning validation based on risk. Key aspects covered include cleaning techniques, establishing acceptance criteria, sampling methods, analytical methods, and documentation requirements. The goal of cleaning validation is to achieve an appropriate level of cleanliness to avoid contamination between product batches.
This presentation includes detail about cleaning levels,equipments for cleaning validation , steps for cleaning method validation and analytical method validation used for cleaning.
This document discusses various concepts related to analytical method validation including accuracy, precision, specificity, detection limit, and quantitation limit. It provides definitions and recommendations for determining each concept. For accuracy, it recommends assessing using spiked samples or an independent procedure and reporting as percent recovery. For precision, it recommends determining repeatability using 9 determinations at 3 concentrations and reporting as standard deviation and coefficient of variation. Detection limit can be determined visually, by signal-to-noise ratio, or by standard deviation of the blank. Quantitation limit is the lowest concentration that can be quantified and can also be determined visually or by signal-to-noise ratio.
The document provides an overview of the qualification process for high performance liquid chromatography (HPLC) equipment, including design qualification (DQ), installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). It describes the objectives and procedures for each qualification step. Key aspects covered include verifying design specifications, proper installation, operational requirements such as precision, accuracy and noise levels, and ongoing performance monitoring. The goal of qualification is to ensure analytical systems are suitable for their intended use and generate reliable results.
This document discusses analytical method validation. It provides definitions and guidelines for validating analytical methods from regulatory agencies. Key aspects of method validation discussed include accuracy, precision, specificity, range, linearity, limits of detection and quantification. Validation parameters are described for different types of analytical tests including identification, quantitative impurity tests and assays. Guidelines are provided for qualifying analytical instrumentation and categorizing instruments based on complexity.
The document discusses analytical method validation, including defining method validation as ensuring an analytical method provides acceptable data for its intended use. It outlines the common steps in method development and validation and the validation parameters that should be assessed, including accuracy, precision, specificity, linearity, range, and robustness. The document provides details on how each of these parameters should be evaluated during the validation process.
QUALIFICATION OF MANUFACTURING EQUIPMENTSANKUSH JADHAV
it gives the information about qualification of various manufacturing equipment which is used into the pharmaceutical labs. (only for information purpose)
Validation is defined as establishing documented evidence that a process will consistently produce results meeting pre-determined specifications. Key aspects of analytical method validation include accuracy, precision, specificity, limit of detection/quantitation, linearity, range, robustness, and system suitability. Validation demonstrates a method is suitable for its intended use and ensures consistent, reliable results are obtained in compliance with regulations.
ANALYTICAL METHOD VALIDATION BY P.RAVISANKAR Dr. Ravi Sankar
This document discusses analytical method validation. It begins with an introduction that defines validation and discusses its importance and regulatory requirements. The document then covers specific validation parameters such as specificity, linearity, accuracy, precision, limit of detection, limit of quantification and more. For each parameter, the document provides definitions, procedures for evaluation, and acceptance criteria. It emphasizes that validation demonstrates a method is suitable for its intended purpose and supports the identity, quality, purity and potency of drug substances and products. The overall summary is that analytical method validation is critical to ensure quality and compliance in the pharmaceutical industry.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
The document discusses the development and validation of an LC-MS/MS bioanalytical method for the determination of a drug in human plasma. It describes the objectives, which are to develop a specific, reliable and cost-effective method. It outlines the key steps in method development including literature search, reference standard preparation, extraction procedure selection, and optimization of separation and detection. The validation parameters that will be evaluated are also summarized, including specificity, accuracy, precision, recovery, matrix effects and stability.
analytical method validation and validation of hplcvenkatesh thota
The document summarizes a seminar on analytical method validation and validation of HPLC. It discusses parameters for method validation according to USP, BP, and ICH guidelines such as accuracy, precision, linearity, range, specificity, detection limit, and quantitation limit. It also covers validation of typical HPLC systems through qualification, design, installation, operational, and performance qualification. Key parameters evaluated during HPLC method validation are discussed, including system suitability tests involving retention factor, relative retention, theoretical plates, resolution, and tailing factor.
The document summarizes the ICH Q2 R1 guideline on the validation of analytical procedures. It discusses the objective of validation, which is to demonstrate that an analytical procedure is suitable for its intended purpose. It describes the types of analytical procedures that should be validated, including identification tests, quantitative impurity tests, limit tests for impurities, and assay procedures. It then goes into detail describing the validation parameters that should be tested, including specificity, accuracy, precision, detection limit, quantitation limit, linearity, range, robustness, and system suitability. The document provides information on how to validate both compendial and non-compendial analytical procedures, as well as the concept of verification for compendial methods
DEVELOPMENT AND VALIDATION OF AN RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATIO...rahul ampati
This document describes the development and validation of an RP-HPLC method for the simultaneous determination of ramipril and amlodipine in tablets. The method utilizes a gradient elution with a C18 column, mobile phase of acetonitrile and sodium perchlorate buffer, and UV detection. The method was validated per ICH guidelines and showed good linearity, accuracy, precision, specificity and robustness. Forced degradation studies demonstrated the method can separate ramipril, amlodipine and their degradation products. The method was successfully applied to determine the content of ramipril and amlodipine in three tablet batches.
The drug or drug combination may not be official in any pharmacopoeias.
A proper analytical procedure for the drug may not be available in the literature due to patent regulations.
Analytical methods may not be available for the drug in the form of a formulation due to the interference caused by the formulation excipients.
Analytical methods for the quantitation of the drug in biological fluids may not be available.
Analytical methods for a drug in combination with other drugs may not be available.
The existing analytical procedures may require expensive reagents and solvents. It may also involve cumbersome extraction and separation procedures and these may not be reliable.
Validation of Analytical and Bioanalytical methodssarikakkadam
Guidelines for Validation of Analytical and Bioanalytical methods as per ICH (Q2R1) and USFDA respectively with an example of Bioanalytical method validation.
Method Validation - ICH /USP Validation, Linearity and Repeatability labgo
1. The document provides an overview of method validation requirements from various regulatory bodies and guidelines. It discusses key validation parameters such as specificity, linearity, range, accuracy, precision, detection limit, and quantitation limit.
2. Validation is required to demonstrate that analytical methods are suitable for their intended purposes. It identifies potential sources of error and quantifies errors in the method. Validation includes parameters like linearity, range, accuracy, and precision.
3. The document provides details on establishing various validation parameters according to regulatory guidelines from ICH, FDA, and USP. It also discusses considerations for validating methods like instrument qualification and defines method life cycles.
Related Substances-Method Validation-PPT_slideBhanu Prakash N
This document provides an overview of analytical method validation. It defines validation as demonstrating a method is suitable for its intended purpose. Key validation characteristics discussed include precision, accuracy, specificity, linearity, range, detection limit, quantitation limit, ruggedness and robustness. The document describes the methodology for evaluating each characteristic, such as spiking known concentrations of analytes and establishing acceptance criteria. It emphasizes that validation confirms a method consistently produces results meeting pre-defined standards of quality.
This document discusses the key aspects of analytical method validation including specificity, linearity, range, accuracy, precision, detection limit, quantitation limit, robustness, and system suitability testing. It provides detailed descriptions and recommendations for establishing each validation characteristic to demonstrate that an analytical procedure is suitable for its intended use.
The document discusses analytical methods and validation. It defines analytical procedures as describing the steps to perform each test. Specifications are defined as lists of tests, procedures, and acceptance criteria that drug substances and products must conform to be approved. General tests include description, identification, assay, and impurities. Specific tests depend on dosage form. Method validation demonstrates reliability and accuracy of results. Key validation parameters discussed include specificity, linearity, range, accuracy, precision, detection and quantitation limits, and robustness. Accuracy is established by comparing results to true values or alternative validated methods across the specified range.
Analytical method development and validation are one of the very imp aspects in Drug testing and approval process.Here I tried to explain the same with my experience.
The document describes the development and validation of UV spectrophotometric methods for analyzing risperidone and lacosamide. It discusses selecting analytical wavelengths, developing standard curves, and validating the methods by determining accuracy, precision, specificity, linearity, range and other parameters as required by ICH guidelines. Validation results for the risperidone and lacosamide methods such as recovery percentages between 98.4-99.8%, precision of 0.67-0.50%, linear ranges of 2-6 μg/ml and 12-40 μg/ml respectively are also presented. The developed and validated methods provide accurate and precise quantification of active pharmaceutical ingredients and finished dosage forms using UV spectrophotometry.
The document discusses analytical and bioanalytical method validation. It defines validation as documented evidence providing a high degree of assurance that a specific process will produce a product meeting predetermined specifications. It describes the key parameters for analytical method validation including specificity, linearity, precision, accuracy, robustness, and validation reporting. For bioanalytical validation, it outlines the basic steps of selectivity, matrix effect, sensitivity, calibration/QC standards, recovery, dilution integrity, carryover, anticoagulant effect, and stability evaluation. The document emphasizes that validation ensures analytical methods and bioanalytical data support drug development and regulatory requirements.
This document discusses analytical method validation for assay methods. It defines validation as demonstrating a method is suitable for its intended purpose. Validation characteristics include precision, accuracy, specificity, linearity, range, ruggedness and robustness. Considerations before validation include calibrated instruments, standardized reagents, trained analysts, test methods and materials. The document describes methodologies for evaluating these characteristics, such as accuracy studies using spiked samples, forced degradation studies for specificity, linearity studies using calibration curves, and ruggedness studies varying analysts, columns, systems and days. Acceptance criteria are provided for each characteristic.
The document discusses analytical method validation. It defines validation as establishing evidence that a process will consistently produce a product meeting predetermined specifications. The objectives are to discuss aspects of validation including principles, approaches, and characteristics. Key steps in validation are establishing accuracy, precision, specificity, linearity, range, limits of detection and quantification, and robustness of analytical procedures used for identification, quantification of impurities and active ingredients.
Calibration and validation of analytical instrumentsSolairajan A
This document discusses the calibration and validation of various analytical instruments used in pharmaceutical analysis. It provides details on calibrating UV-Vis spectrophotometers, IR spectrophotometers, spectrofluorimeters, HPLC, and GC. Calibration ensures instrument readings are accurate against standards, while validation confirms the instrument is correctly installed and operating as intended. The document outlines tests and acceptance criteria for evaluating characteristics like wavelength accuracy, resolution, noise, baseline flatness, sensitivity, flow rate, and linearity during calibration and validation of different analytical instruments.
This document discusses guidelines for analytical method validation. It outlines types of analytical methods that require validation including chromatographic, spectroscopic, and dissolution methods. Key analytical performance characteristics used in validation are described such as specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. The document provides details on determining these characteristics and validating methods. It also addresses revalidation and references for further information.
Differential scanning calorimetry (DSC) is a technique used to study thermal transitions in polymers and other materials. It works by heating a sample and reference simultaneously while measuring the difference in energy required to keep them at the same temperature. This allows thermal transitions like glass transitions, crystallization, and melting to be identified by features in the resulting DSC curve. The technique provides both qualitative and quantitative information about these transitions.
This document provides an overview of analytical method validation. It discusses key validation characteristics such as specificity, linearity, range, accuracy, precision, LOD and LOQ. Guidelines for validation from organizations like ICH, USP, ANVISA and AOAC are also mentioned. The document describes procedures for establishing various validation parameters and evaluating the results. It emphasizes that validation is necessary to ensure analytical methods consistently provide reliable results.
This document discusses guidelines for validating analytical methods from the International Council for Harmonisation (ICH). It defines method validation as demonstrating that analytical procedures are suitable for their intended use. Key parameters of method validation discussed include specificity, linearity, range, accuracy, precision, detection and quantitation limits, ruggedness and robustness. The guidelines provide criteria for acceptance in each parameter area to ensure analytical methods are suitable to support the quality and potency of pharmaceutical products.
This document discusses analytical method validation. It provides guidance on validation from various organizations. It describes the types of analytical procedures that require validation including chromatographic, spectroscopic, and dissolution methods. Key validation characteristics that should be considered include specificity, linearity, range, accuracy, precision, detection limit, quantitation limit, robustness, and system suitability. The document provides details on how these characteristics should be determined during the validation process. It also discusses circumstances under which revalidation may be necessary such as changes to the drug synthesis or analytical method.
This document discusses analytical method validation. It introduces the importance of validating analytical procedures to ensure accurate and precise results. It describes common validation characteristics including accuracy, precision, specificity, linearity, range, detection/quantitation limits, and robustness. The document provides detailed definitions and procedures for evaluating each validation characteristic to demonstrate an analytical method is fit for its intended use.
This document summarizes guidelines for analytical method validation from various regulatory agencies. It discusses the purpose of validation to verify method suitability. Key analytical performance characteristics covered include specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. It notes that revalidation may be necessary if the analytical method or drug product is changed.
This document summarizes guidelines for analytical method validation from various regulatory agencies. It discusses the purpose of validation to verify method suitability for submissions. Key validation characteristics covered include specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. It notes that revalidation may be necessary if the analytical method or drug product is changed.
Validation is defined as establishing documented evidence that a process will consistently produce a product meeting specifications. Analytical methods must be validated for identification tests, quantitative tests for impurities, limit tests, and assays. Key parameters for validation include linearity and range, specificity, precision, accuracy, limits of detection and quantification, robustness, and system suitability. Validation demonstrates a method is suitable for its intended use by proving the method is accurate, precise, specific, robust, and capable of detecting analytes at low concentrations.
This document discusses guidelines for analytical method validation. It outlines the types of analytical methods that require validation including chromatographic, spectroscopic, and dissolution methods. It describes key performance characteristics that are evaluated in validation studies such as specificity, accuracy, precision, linearity, range, detection and quantitation limits, and robustness. The document provides details on how these characteristics are tested and the acceptance criteria used to ensure the method is suitable for its intended purpose. It also discusses circumstances under which revalidation may be necessary.
Analytical Method Validation basics by Dr. A. AmsavelDr. Amsavel A
This document discusses analytical method validation which is the process of confirming that an analytical method is suitable for its intended purpose. Key aspects of method validation discussed include accuracy, precision, specificity, linearity, range, detection limit, quantitation limit, repeatability and intermediate precision. The document outlines validation parameters for different types of analytical methods and provides examples of acceptance criteria. It also discusses guidance from regulatory agencies on analytical method validation.
The document discusses analytical method validation. It provides an overview of the International Conference on Harmonization (ICH) which aims to harmonize regulatory requirements between Europe, Japan and the United States. It then discusses the key parameters of method validation including specificity, accuracy, precision, linearity, range, robustness, limit of detection, limit of quantification and system suitability. The document provides guidelines on testing and evaluating each validation parameter according to regulatory standards. It emphasizes that analytical methods must be validated before use and whenever the method is changed to ensure reliable and reproducible results.
This document discusses validation of analytical procedures. It is divided into two parts. Part I provides definitions and discusses typical validation characteristics such as accuracy, precision, specificity, detection limit, and quantitation limit. Part II provides more detailed methodology guidance on how to validate these characteristics. It describes how to validate specificity, accuracy, precision, detection limit, quantitation limit, linearity, range, and robustness of analytical procedures. The goal of validation is to demonstrate that analytical procedures are suitable for their intended purpose in identifying, quantifying, and testing impurities in drug substances and products.
The document discusses validation of analytical procedures. Validation is required to confirm a procedure is suitable for its intended use. It identifies potential errors and determines if the method is acceptable. Key validation characteristics discussed include specificity, linearity, range, accuracy, precision, limit of detection, limit of quantitation, robustness, and system suitability. The document provides details on how to evaluate each characteristic.
The document discusses analytical method validation which is required by pharmaceutical GMPs. It defines analytical method validation as establishing that a method's performance characteristics meet requirements for its intended purpose through laboratory studies. The key steps of validation include specificity, linearity, accuracy, precision, range, detection/quantitation limits, and robustness. Validation ensures testing methods are suitable and reliable for their intended use in pharmaceutical quality control.
This document outlines guidelines for analytical method validation as described in ICH Q2. It defines validation as establishing evidence that a method is suitable for its intended purpose. Key parameters that must be validated include accuracy, precision, specificity, detection limit, quantitation limit, linearity, range, and robustness. The guidelines provide details on how to validate these parameters and determine method suitability.
This document provides a summary of analytical method validation. It discusses the types of analytical procedures that should be validated, including identification tests, quantitative impurity tests, limit tests, and active moiety assays. It also summarizes key validation characteristics that should be considered, such as accuracy, precision, specificity, range, detection limit, quantitation limit, linearity, and robustness. The document provides definitions and methodology recommendations for validating analytical procedures. It emphasizes that the validation process verifies that an analytical method is suitable for its intended purpose.
International conference on harmonisation validation of analytical proceduresnoushin javidvand
This document provides guidance on validating analytical procedures according to the International Conference on Harmonization. It defines key terms and outlines the validation characteristics that should be evaluated for identification tests, assays for active ingredients or impurities. These include accuracy, precision, repeatability, specificity, detection limit, quantitation limit, linearity, range, and robustness. The document provides detailed methodology for testing each validation characteristic on analytical procedures to demonstrate the procedure is suitable for its intended use.
Analytical Development of methods in biologicsambrish48
This document discusses analytical method validation. It defines validation as establishing by laboratory studies that a method's performance characteristics meet requirements for its intended use. The key validation parameters discussed are accuracy, precision, specificity, linearity, range, detection limit, quantitation limit, robustness, ruggedness, noise, trueness and sensitivity. Accuracy measures exactness, precision measures reproducibility, and specificity and selectivity differentiate between analytes. Linearity, range, detection limit and quantitation limit define the method's quantitative ability. Robustness and ruggedness evaluate reliability under variations.
validation of analytical procedure USFDA GuidlineArchana Chavhan
The document discusses the validation of analytical procedures as outlined by regulatory agencies like the USFDA. It defines key terms like accuracy, precision, specificity, detection limit, quantitation limit, linearity, range, and robustness. For each term, it provides the definition and recommendations on how to determine the characteristic during the validation process, such as testing a minimum number of samples over a specified range and concentration levels. The overall purpose of the validation is to establish that the analytical procedure is suitable for its intended use.
The joint EASD (European Association for the Study of Diabetes) and ADA (American Diabetes Association) Consensus Report on the management of hyperglycaemia in type 2 diabetes serves as a comprehensive, evidence-based guide to help clinicians provide patient-centered care. Updated regularly, the report reflects evolving scientific evidence, advances in pharmacological therapies, and a growing emphasis on individualization of treatment.
The 2022 edition emphasizes a holistic approach to managing type 2 diabetes, integrating lifestyle interventions, glucose-lowering medications, cardiovascular and renal risk reduction, and patient preferences. The report moves beyond strict glycemic targets alone and promotes the consideration of comorbid conditions—such as cardiovascular disease, chronic kidney disease (CKD), and obesity—when choosing therapies.
The document highlights the importance of metformin as a foundational therapy but recommends early use of SGLT2 inhibitors or GLP-1 receptor agonists in patients with established cardiovascular or renal disease, regardless of HbA1c levels. These classes offer benefits beyond glucose control, including heart failure risk reduction and kidney protection.
A key feature of the consensus is its endorsement of shared decision-making, taking into account patient goals, preferences, access, and affordability. The report also discusses the role of digital health tools, continuous glucose monitoring, and team-based care in improving outcomes.
Glycemic targets are individualized, typically aiming for an HbA1c of <7%, but allowing flexibility based on age, duration of diabetes, comorbidities, and risk of hypoglycemia. The report also underscores the need for regular reassessment, treatment intensification when needed, and ongoing patient education.
Overall, the EASD-ADA consensus provides a dynamic framework that supports a multifaceted, patient-centric approach to type 2 diabetes care, aiming to reduce complications, improve quality of life, and promote long-term health outcomes.
The oral cavity is the site where food is received and therefore an area of body where contact with exogenous material, microorganism and harmful agents is particularly intense.
The oral mucosa functions as a mechanical as well as immunological barrier
Inflamed lesion, keratosis as well as premalignant and malignant changes in mucosa may be diagnosed on macroscopic inspection and palpation. Squamous cell carcinoma accounts for more than 90% of oral malignancies.
Oral cancer is the most common cancer in India, with the incidence of 30–50% of whole body tumours, of which squamous cell carcinoma (SCC) arises from stratified squamous epithelium.
Cell Survival Curve (Radiobiology) Dr Syed Aman.pptxSyed Aman
Eric J Hall Radiobiology 3rd Chapter simplified.
Cell survival curve describes relationship between radiation dose and proportion of cells that survive.
It includes clips from Dr Manoj Gupta Sir's class.
A 4TH FREE WORKSHOP/
BONUS SESSION 2
Reiki Yoga “Clearing”
Our Sessions 1-3 are available for download notes. Thx for Reading.
https://ko-fi.com/ldmmia
Celebrating my 49th Bday.
A Taurus Sun, Born early May 3rd, “76”.
Also A Gemini Moon/Rising. I follow Both signs.
Welcome to the 2nd Bonus Session.
Beyond Basics - Good Vibes Only:
—Review - Good Vibes Only:
— For me, within both Reiki and Yoga sessions the essentials boost the energy. Energy can also be called Vibrations and Frequency. So many coaches are specializing within Frequency topics. They can coach entire themes using Frequency success stories. This shows how little we think of energy? We need our coaches to boost our wisdom? To boost the vibes? For Reiki & Yoga Therapy, using ‘Props’ can assist, protect, and heal energies - faster/better. Let’s Explore more.
(See Presentation for all sections, THX)
Clear Your Energy Pt 1…(See Presentation)
Clear Your Energy - Pt 2
I know we operate busy schedules. Sometimes I will yoga stretch, do warm ups, Fuse Qigong, and clear my chakras. It can be therapy or for energy boosts. So many things within our activities will leave behind energy. This can be positive or negative. We assume these energies naturally drop off. But, not always the case. Some energies latch on longterm. This all depends on your moods, emotions, and lifestyle. Hope it makes sense. We have to monitor our energy intake/out-take.
Repost:
Taking breaks, pausing, relaxing, are common things ppl struggle with. Including at times, myself. Reiki requires chill hours or meditations. We often believe our schedules are badges to display for social/approval? This is a generational society belief. It takes courage to bold/quietly declare - the opposite.
(Old Matrix Systems)
Energy Monitoring-The Media/News
A Perm bonus section I wanted to keep. This is about The media and news. Now, I understand it’s hard to avoid all news. Especially when we need our global, local, weather, and economic updates. Some news are important while others are extremely negative. Anything hosting bad vibes can be draining. I have seen this occur within distant/visual updates like news or gossip. We have to keep what we need. Then leave behind what we don’t. The intuitive coaching/Tarot rules.
There’s a lot going on for every country. So now is the time to practice calming methods for daily life or emergencies.
(See Presentation for all, new topics, THX)
To Donate/Tip/Love Offerings:
♥¸.•♥ ♥¸.•♥
- https://ko-fi.com/ldmmia
- CashApp: $ldmmia2 or https://ldmchapels.weebly.com
Public Social:
https://www.instagram.com/chelleofsl/
https://x.com/OnlineDrLeZ
Hello friends, welcome to Dubey Clinic!
If you are a male and looking for a sexologist doctor for personal treatment or medicine then this information is helpful for you. As we know a sexologist doctor is a specialist in his medical faculty to treat patients who are suffering from any kind of sexual problems. He is a specialist in the study of sexuality, sexology, sexual dysfunction, sexual desire, behavior, gender-identity, anatomy and reproductive health issues. He practices in a clinic or hospital to provide his treatment and medicine privileges.
World renowned Ayurvedacharya Dr. Sunil Dubey is the best sexologist doctor in Patna, Bihar who provides his comprehensive treatment for married and unmarried people at Dubey Clinic. He is a highly qualified Ayurvedic doctor who is an expert in sexology medicine and therapy. In his treatment, he uses the entire branches of Ayurveda (modern, traditional, specific and others) to treat his sexual patients. He is also a successful researcher in this Ayurvedic sexologist profession who has successfully done his research on various sexual diseases in men and women.
Common Sexual Problems in men:
Based on his daily practice, treatments and research; he says that both married and unmarried men can struggle with their sexual problems. He says that men struggle with erectile dysfunction, premature ejaculation, lack of sexual desire, culture-specific syndromes, ejaculation disorders, sexually transmitted infections, performance anxiety disorder and other sexual problems. Various factors are responsible for sexual problems and among them; physical, psychological, lifestyle, hormonal, medical conditions and emotional factors play a vital role in leading a person to sexual problems.
Ayurvedic Treatment for Overall Male Sexual Problems:
Dr. Sunil Dubey says that Ayurveda has infallible solutions to deal with all sexual problems of men. The approach of Ayurveda focuses on balancing the doshas in the body, which are the cause of sexual disorders. It has a natural system to cure problems, which is the basis of all medicines. He provides his comprehensive treatment to each and every sexual patient with the help of Ayurveda.
First, he identifies the underlying medical conditions (diabetes, cardiac problems, kidney disease and chronic illness) that play a vital role in this sexual problem. He also helps in identifying psychological factors (stress, depression, anxiety, relationship issues and emotional factors) that indirectly affect sexual health. Providing a holistic approach of treatment, he provides clinically proven Ayurvedic medicine, herbal remedies, quality-proven Ayurvedic Bhasma and vital guidance of sexual wellness.
!!!For further Information, join Web Info: https://ayurvedacharyadrsunildubey.com/
More Info: https://ayurvedacharyadrsunildubey.com/best-sexologist-in-patna
Facebook: https://www.facebook.com/DubeyClinicPatna
#sexologist #bestsexologist #bestsexologistpatna #bestsexologistbihar #drsunildubey
Wound healing in periodontology is a complex biological process that occurs following periodontal surgery or injury to the tissues of the periodontium, including the gingiva, periodontal ligament, cementum, and alveolar bone. The goal is to restore the damaged tissues and promote functional healing, minimizing complications such as infection or tissue breakdown.
The process can be divided into four main stages: hemostasis, inflammation, proliferation, and remodeling.
1. **Hemostasis**: Immediately following surgery or injury, the body works to stop bleeding through blood clot formation, which serves as a protective barrier and a matrix for tissue regeneration.
2. **Inflammation**: This phase is characterized by the body's immune response to clear debris and bacteria. It typically lasts for a few days and involves the influx of inflammatory cells like neutrophils and macrophages, which aid in cleaning the wound site and preventing infection.
3. **Proliferation**: During this phase, the body begins to rebuild the damaged tissues. Fibroblasts proliferate, synthesizing collagen and extracellular matrix components. New blood vessels form in a process called angiogenesis, which ensures a steady supply of nutrients and oxygen for tissue repair. This phase also involves epithelial migration over the wound site, covering the exposed tissue.
4. **Remodeling**: The final stage is characterized by the maturation of the tissue, where collagen fibers are reorganized and the wound strengthens over time. This phase can last for several months, as the tissues return to their normal structure and function.
Successful wound healing in periodontics is crucial for long-term outcomes, such as tissue regeneration, improved periodontal health, and prevention of further periodontal damage.
PELVIC LYMPH NODES TARGET DELINEATION Dr Syed Aman.pptxSyed Aman
Pelvic Organs their lymphatic drainage and target delineation for contouring in Cervical cancer, rectal cancer and anal cancer for Radiation Oncologists.
Role of Gene Therapy Neurological disordersriggdiana2
Gene therapy stands at the frontier of medical innovation, particularly in the realm of neurological disorders, offering new hope for conditions that have historically had limited treatment options. The presentation titled "Gene Therapy in Neurological Disorders" thoroughly examines how advances in gene-editing technologies are transforming the diagnosis, treatment, and management of diseases affecting the central nervous system (CNS). It introduces gene therapy by explaining its basic concepts, historical evolution, and major techniques, including viral vector-based methods such as adeno-associated viruses (AAV) and lentiviruses, as well as newer CRISPR-based genome editing strategies.
Focusing on neurological disorders, the presentation explains the rationale behind targeting these diseases, noting their high burden on individuals and healthcare systems, and emphasizing that many neurological conditions have well-understood genetic causes. Mechanisms of gene therapy delivery, such as in vivo and ex vivo approaches, are described along with challenges like crossing the blood-brain barrier, achieving target specificity, and avoiding adverse immune responses.
Several landmark applications are highlighted, including the success story of Spinal Muscular Atrophy (SMA) gene therapy using Zolgensma, gene delivery strategies for Parkinson’s Disease focusing on neuroprotection through GDNF gene expression, and approaches for Alzheimer's Disease aimed at reducing amyloid-beta and tau pathology. Emerging technologies such as CRISPR base editing in the CNS and the use of nanoparticles to facilitate gene delivery represent the next frontier in gene therapy for neurological disorders.
Ethical considerations are explored in-depth, including risk-benefit analysis in irreversible interventions, informed consent complexities, and debates surrounding germline versus somatic therapy. Case studies from SMA and Parkinson’s Disease gene therapy trials illustrate the profound impact and the significant hurdles faced in clinical implementation.
Looking ahead, the presentation discusses future prospects such as enhanced delivery systems, precision targeting, and highly personalized gene therapy approaches that could revolutionize neurological care. Overall, gene therapy is presented as an exciting yet challenging frontier, requiring scientific innovation, rigorous ethical scrutiny, and comprehensive regulatory frameworks to ensure that its full potential can be safely and equitably realized for individuals suffering from devastating neurological disorders
Looking ahead, the presentation discusses future prospects such as enhanced delivery systems, precision targeting, and highly personalized gene therapy approaches that could revolutionize neurological care. Overall, gene therapy is presented as an exciting yet challenging frontier, requiring scientific innovation, rigorous ethical scrutiny, and comprehensive regulatory frameworks to ensure that its full potential
BIOMECHANICS & KINESIOLOGY OF THEHIP COMPLEX.pptxdrnidhimnd
The cuplike concave socket of the hip joint is called the acetabulum and is located on the lateral aspect of the pelvic bone (innominate or os coxa).
Until full ossification of the pelvis occurs between 20 and 25 years of age.
The periphery of the acetabulum (lunate surface) is covered with hyaline cartilage.
This horseshoe-shaped area of cartilage articulates with the head of the femur and allows for contact stress to be uniformly distributed.
The inferior aspect of the lunate surface (the base of the horseshoe) is interrupted by a deep notch called the acetabular notch.
The acetabular notch is spanned by a fibrous band, the transverse acetabular ligament, that connects the two ends of the horseshoe.
The acetabulum is deepened by the fibrocartilaginous acetabular labrum, which surrounds the periphery of the acetabulum. The acetabular fossa is non-articular; the femoral head does not contact this surface.
The acetabular fossa contains fibroelastic fat covered with synovial membrane.
Basic drug information resources:
Drug information is current, critically examined, relevant data about drugs and drug use in a given patient or situation.
Current information uses the most recent, up-to-date sources possible.
Critically examined information.
Relevant information must be presented in a manner that applies directly to the circumstances under consideration (e.g. patient parameters, therapeutic objectives, alternative approaches).
SUB- Herbal and cosmetic analysis –II(MPA204T)
Evaluation Of Cosmetic Products
Indian Standard Specification
Bureau Indian Standards.
Comprehensive Analysis Of Raw Materials And Finished Products
PRESENTED BY-DHANASHREE G. KOLHEKAR (2nd SEM), M.PHARMACY (PHARMACEUTICAL ANALYSIS)
Introduction
Importance of Cosmetic Product Evaluation
Ensures safety, quality, and regulatory compliance
Impacts consumer trust and product effectiveness
Objectives of the Presentation
Understand evaluation methods for cosmetics.
Discuss BIS standards for raw materials and finished products
Analyze quality control parameters.
Normal distribution and Z score Test for post graduate and undergraduate stu...Tauseef Jawaid
Normal distribution and Z score
The normal distribution is also known as a Gaussian distribution or probability bell curve.
It is symmetric about the mean and indicates that values near the mean occur more frequently than the values that are farther away from the mean
According to the CIOMS/WHO working group on vaccine pharmacovigilance,
Vaccine pharmacovigilance is defined as
“The science and activities relating to the” Detection, Assessment, Understanding and Communication of adverse events following immunization and other vaccine or immunization-related issues, and to the prevention of untoward effect of the vaccine or immunization
2. REGULATORY GUIDELINES
ICH-Q2R1/Q2A “Text on Validation of Analytical
Procedure (1994)
ICH-Q2R1/Q2B “Validation of Analytical Procedures
Methodology (1995)
CDER “Reviewer Guidance: Validation of
Chromatographic Method” (1994)
8/19/2015 2Analytical Method Validation
3. REGULATORY GUIDELINES
CDER “Submitting Samples and Analytical Data for
Method Validations” (1987)
CDER Draft “Analytical Procedures and Method
Validation” (2000)
CDER “Bioanalytical Method Validation for Human
Studies” (1999)
USP<1225> “Validation of Compendial Methods”
8/19/2015 3Analytical Method Validation
4. CONSIDERATIONS PRIOR TO
METHOD VALIDATION
Suitability of Instrument
Status of Qualification and Calibration
Suitability of Materials
Status of Reference Standards, Reagents, etc
Suitability of Analyst
Status of Training and Qualification Records
Suitability of Documentation
Written analytical procedure and proper approved protocol with
pre-established acceptance criteria.
8/19/2015 4Analytical Method Validation
5. TYPES OF ANALYTICAL
PROCEDURES TO BE
VALIDATED
1. Identification tests.
2. Quantitative tests for impurities content.
3. Limit tests for the control of impurities .
4. Quantitative tests of the active moiety in samples of drug
substance.
5. Bioanalytical methods.
6. Stability indicating methods.
8/19/2015 5Analytical Method Validation
6. VALIDATION
Definition -
Validation of an analytical procedure is the process by which it
is established, by laboratory studies, that the performance
characteristics of the procedure meet the requirements for the
intended analytical applications.
8/19/2015 Analytical Method Validation 6
9. DATA ELEMENTS REQUIRED
FOR ASSAY VALIDATION
Category I: Analytical methods for quantitation of major
components of bulk drug substances
Category II: Analytical methods for determination of
impurities in bulk drug substances
Category III: Analytical methods for determination of
performance characteristics
Category IV: Identification tests.
8/19/2015 Analytical Method Validation 9
11. ACCURACY
Definition-
The accuracy of an analytical procedure is the closeness of
test results obtained by that procedure to the true value.
Determined by application of the analytical procedure to an
analyte of known purity (e.g. A Reference Standard).
Accuracy should be assessed using a minimum of nine
determinations over a minimum of three concentration
levels, covering the specified range.(i.e. Three concentrations
and three replicates of each concentration).
8/19/2015 Analytical Method Validation 11
12. ACCURACY
8/19/2015 Analytical Method Validation 12
Should be reported as:
Percent recovery of known amount added or
the difference between the mean assay result and the accepted
value.
Assessment of accuracy –
Evaluating the recovery of the analyte (percent recovery) across
the range of the assay, or evaluating the linearity of the
relationship between estimated and actual concentrations.
14. PRECISION
8/19/2015 Analytical Method Validation 14
Definition-
It is the degree of agreement among individual test results
when the procedure is applied repeatedly to multiple
samplings of a homogeneous sample.
Precision may be a measure of either the degree of
reproducibility or of repeatability of the analytical procedure
under normal operating conditions.
15. PRECISION
Repeatability should be assessed using a minimum of nine
determinations covering the specified range for the procedure
(i.e., three concentrations and three replicates of each
concentration or using a minimum of six determinations at
100% of the test concentration).
8/19/2015 Analytical Method Validation 15
16. (PRECISION)
1.REPEATABILITY
Precision Considered at 3 Levels
1. Repeatability- Express the precision under the same
operating conditions over a short interval of time. Also
referred to as Intra-assay precision.
Should be assessed using minimum of 9 determinations
( 3 concentrations/ 3 replicates) or
Minimum of 6 determinations at the 100% level.
8/19/2015 Analytical Method Validation 16
17. 2.INTERMEDIATE PRECISION
Express within-laboratory variations.
Expressed in terms of standard deviation, relative standard
deviation (coefficient of variation) and confidence interval.
Studies should include varying days, analysts, equipment,
etc.
Depends on the circumstances under which the procedure is
intended to be used.
8/19/2015
Analytical Method Validation
17
18. 3.REPRODUCIBILITY
Ability reproduce data within the predefined precision
Determination: SD, RSD and confidence interval
8/19/2015 Analytical Method Validation 18
19. ACCURACY AND PRECISION
8/19/2015 Analytical Method Validation 19
Accurate &
precise
Accurate &
imprecise
Inaccurate &
precise
Inaccurate &
imprecise
20. SPECIFICITY
Definition -
Its the ability to assess unequivocally the analyte in the
presence of components that may be expected to be
present, such as impurities, degradation products, and
matrix components.
IUPAC, AOAC-I have preferred the term “selectivity,”
reserving “specificity” for those procedures that are
completely selective.
8/19/2015 Analytical Method Validation 20
21. SPECIFICITY
Specificity has the following implications:
Identification Tests: Ensure the identity of the analyte.
Purity Tests: Ensure that all the analytical procedures
performed allow an accurate statement of the content of
impurities of an analyte (e.g. related substances test, heavy
metals limit, organic volatile impurities).
Assays: Provide an exact result, which allows an accurate
statement on the content or potency of the analyte in a
sample.
8/19/2015 Analytical Method Validation 21
22. SPECIFICITY
Determination -
If impurity or degradation product standards are
unavailable, compare the test results of samples containing
impurities or degradation products to a second well-
characterized procedure (e.g., a Pharmacopeial or other
validated procedure).
The ICH documents state that when chromatographic
procedures are used, representative chromatograms should be
presented to demonstrate the degree of selectivity, and peaks
should be appropriately labeled.
8/19/2015 Analytical Method Validation 22
23. DETECTION LIMIT
Definition -
It is the lowest amount of analyte in a sample that can be
detected, but not necessarily quantitated, under the stated
experimental conditions.
The detection limit is a characteristic of limit tests.
Its usually expressed as the concentration of analyte (e.g.,
percentage, parts per billion) in the sample.
8/19/2015 Analytical Method Validation 23
24. DETECTION LIMIT
Determination -
For non instrumental procedures -
• Generally determined by the analysis of samples with known
concentrations of analyte and by establishing the minimum
level at which the analyte can be reliably detected.
For instrumental procedures -
• That exhibit background noise, which is to compare measured
signals from samples with known low concentrations of
analyte with those of blank samples.
• [Acceptable signal-to-noise ratios are 2:1 or 3:1.]
8/19/2015 Analytical Method Validation 24
25. QUANTITATION LIMIT
Definition-
It is the lowest amount of analyte in a sample that can
be determined with acceptable precision and accuracy
under the stated experimental conditions.
The quantitation limit is a characteristic of quantitative
assays for low levels of compounds in sample matrices, such
as impurities in bulk drug substances and degradation
products in finished pharmaceuticals.
8/19/2015 Analytical Method Validation 25
26. QUANTITATION LIMIT
Determination -
For non instrumental procedures -
• Determined by the analysis of samples with known
concentrations of analyte
For instrumental procedures -
• the ICH documents describe a common approach, which is to
compare measured signals from samples with known low
concentrations of analyte with those of blank samples.
[A typically acceptable signal-to-noise ratio is 10:1.]
8/19/2015 Analytical Method Validation 26
27. LINEARITY
• Definition -
Its ability to elicit test results that are directly, or by a
well-defined mathematical transformation, proportional to
the concentration of analyte in samples within a given
range.
• “linearity” refers to the linearity of the relationship of
concentration and assay measurement.
8/19/2015 Analytical Method Validation 27
28. LINEARITY
By Visual Inspection of plot of signals vs. analyte
concentration
By Appropriate statistical methods
Linear Regression (y = mx + b)
Correlation Coefficient, y-intercept (b), slope (m)
Acceptance criteria: Linear regression r2 > 0.95
Requires a minimum of 5 concentration levels
8/19/2015 Analytical Method Validation 28
29. RANGE
Definition -
Its the interval between the upper and lower levels of
analyte (including these levels) that have been
demonstrated to be determined with a suitable level of
precision, accuracy, and linearity using the procedure as
written.
8/19/2015 Analytical Method Validation 29
30. RANGE
• For Drug Substance & Drug product Assay
– 80 to 120% of test Concentration
• For Content Uniformity Assay
– 70 to 130% of test Concentration
• For Dissolution Test Method
– +/- 20% over entire Specification Range
• For Impurity Assays
– From Reporting Level to 120% of Impurity
Specification for Impurity Assays
– From Reporting Level to 120% of Assay Specification
for Impurity/Assay Methods
8/19/2015 Analytical Method Validation 30
31. ROBUSTNESS
Definition –
• It’s the measure of its capacity to remain unaffected by
small but deliberate variations in procedural parameters
listed in the procedure documentation and provides an
indication of its suitability during normal usage.
Examples of typical variations are:
• Stability of analytical solutions
• Extraction time.
8/19/2015 Analytical Method Validation 31
32. ROBUSTNESS
In the case of LC, examples of typical
variations are:
• - influence of variations of pH in a mobile phase.
• - influence of variations in mobile phase composition.
• - different columns (different lots and/or suppliers)
• - temperature.
• - flow rate.
8/19/2015 Analytical Method Validation 32
33. RUGGEDNESS
Degree of reproducibility of test results under a variety of
conditions
Different Laboratories
Different Analysts
Different Instruments
Different Reagents
Different Days
Expressed as %RSD
8/19/2015 Analytical Method Validation 33
34. SYSTEM SUITABILITY
ICH
ICH
Definition: evaluation of equipment, electronic,
analytical operations and samples as a whole
Determination: repeatability, tailing factor (T), capacity
factor (k’), resolution (R), and theoretical Plates (N)
8/19/2015 Analytical Method Validation 34
35. SYSTEM SUITABILITY
USP
• USP 23 <621> :
8/19/2015 Analytical Method Validation 35
Parameters Recommendations
K In general k ≥ 2.0
R
R > 2, between the peak of
interest and the closest potential
interferences(degradant, internal
Std, impurity, excipient etc)
T T ≤ 2
N In general N > 2000
Repeatability RSD ≤ 2.0% (n ≥ 5)
37. PURPOSE OF STUDY
• The stability-indicating LC assay method was developed and
validated for quantitative determination of cefcapene pivoxil
in the presence of degradation products formed during forced
degradation studies.
• The method was validated with regard to linearity, accuracy,
precision, selectivity, and robustness.
• HPLC method was validated according to the International
Conference on Harmonization Guidelines (ICH Q2B,
validation of analytical procedures, methodology)
8/19/2015 Analytical Method Validation 37
38. SELECTIVITY
• The selectivity was examined for non-degraded and degraded
samples.
• The HPLC method for determination of cefcapene pivoxil was
found selective in the presence of degradation products.
• The peak purity values were more than 98.79 % for cefcapene
pivoxil at 270 nm, what proves that degradants were not
interfering with the mean peak.
8/19/2015 Analytical Method Validation 38
39. TABLE 1: RESULTS OF FORCED
DEGRADATION STUDIES.
• Peak purity values in the range of 98.5–100 indicates a
homogeneous.
• peak
8/19/2015 Analytical Method Validation 39
Stress conditions and
time studies
Degradation(%) Peak purity
Acidic/0.5 mol L-1
HCl/363 K/240 min
56.4 100.00
Oxidizing/30 %
H2O2/343 K/310 min
88.7 98.79
Thermal/373 K/28 days 9.4 100
Thermal/393 K/28 days 30.9 100
Radiolytic/25 kGy 1.7 99.98
Radiolytic/400 kGy 10.8 99.15
40. LINEARITY
• Linearity was evaluated in the concentration range 20–240 mg
L-1.
• The samples of each solution were injected three times and
each series comprised six experimental points.
• The calibration plots were linear in the following
concentration range 20–240 mg L-1 (n = 6, r = 0.9992).
• Statistical analysis using Mandel’s fitting test confirmed
linearity of the calibration curves.
8/19/2015 Analytical Method Validation 40
41. PRECISION
• Precision of the assay was determined in relation to
repeatability (intra-day) and intermediate precision
(interday).
• six samples were determined during the same day for three
concentrations of cefcapene pivoxil.
• The RSD values were 0.58 and 1.27 %, respectively,
demonstrating that the method was precise.
8/19/2015 Analytical Method Validation 41
43. ACCURACY AS RECOVERY
TEST
• The accuracy of the method was determined by recovering
cefcapene pivoxil from the placebo.
• The recovery test was performed at three levels 80, 100, and
120 %.
• Three samples were prepared for each recovery level.
8/19/2015 Analytical Method Validation 43
44. LOD AND LOQ :
• The LOD and LOQ parameters were determined from the
regression equation of cefcapene pivoxil.
• LOD = 3.3 Sy/a , LOQ = 10 Sy/a.
• where Sy is a standard error and a is the slope of the
corresponding calibration curve.
8/19/2015 Analytical Method Validation 44
48. • Recovery studies and validation of the method
(As per ICH Q2A Guidelines) :
• Recovery studies were carried out by adding 1, 2 and 3 mg of
pure drug to different samples of tablet powder containing the
equivalent of 10 mg of drug.
• Percentage recovery was calculated from the amount
obtained by recovery studies.
• Precision of the method was studied by carrying out intraday,
interday analysis and expressed as % Relative Standard.
8/19/2015 Analytical Method Validation 48
49. RESULTS AND DISCUSSION
• In this proposed method, the determining conditions were
established by varying one parameter at a time and keeping the
other fixed by observing the effect produced on the
absorbance of a complex.
• The parameters involves the maximum complex
development viz. concentration of reagent, temperature
and time required to yield complex of maximum sensitivity
were optimized.
• The proposed method was found to be accurate, simple and
rapid for routine analysis of cephalexin.
8/19/2015 Analytical Method Validation 49
51. • This method was based on the reaction of NBS with aromatic
amines in an acidic medium to form a brominating colored
product.
• Cephalexin is let to react with a known excess of NBS in
acidic media.
• This caused a proportional decrease in the concentration and
absorbance of formed color in the mixture by an increase in
concentration of cephalexin.
8/19/2015 Analytical Method Validation 51
52. STUDY OF INTERFERENCES BY
COMMON EXCIPIENTS
8/19/2015 Analytical Method Validation 52
Name
MAC*,μ
g/mL
Cephalexin,μg/mL Recovery
%
TCR**
Added Found**
Glucose 50 15 15.20 101.33 3.33
Fructose 50 15 15.12 100.80 3.33
Sucrose 50 15 14.90 99.26 3.33
Starch 50 15 14.80 99.16 3.33
Ca2+ 100 15 15.10 100.66 6.67
CO32- 100 15 14.99 99.66 6.67
*Maximum allowable concentrations, **Mean of three replicate analyses, TCR: Tolerable
Concentration Ratio with no interferences (Interferent (μg/mL) / Cephalexin (μg/mL))
55. PURPOSE OF STUDY
An LC–MS/MS method was developed to measure SIM and
its acid form (SIMA) in plasma and peripheral blood
mononuclear cells (PBMCs) obtained from patients.
Chromatographic analyte separation was carried out on a
reverse-phase column using 75:25 (% v/v)
acetonitrile:ammonium acetate (0.1M, pH 5.0) mobile phase.
The assay was validated for specificity and sensitivity,
linearity, precision and accuracy, extraction recovery, matrix
effect, and stability
8/19/2015 Analytical Method Validation 55
56. SPECIFICITY AND SENSITIVITY
• Assay specificity and sensitivity were conducted in eight
different lots of blank plasma that was either left blank or
spiked with both analyte and IS.
• The lowest limit of quantitation (LLOQ) was assessed in the
same plasma lots used for specificity.
• The determination of LLOQ was based on the criteria that the
deviation of the measured concentrations should NMT 20%
from the nominal concentration and that the signal to noise
ratio be ≥5.
8/19/2015 Analytical Method Validation 56
57. LINEARITY
• Linearity was evaluated using plasma samples spiked with
both SIM and SIMA at concentration ranges 2.5–500 ng/mL
and 5–500 ng/mL, respectively.
• The internal standard LOV, concentration was 50 ng/mL in all
calibration standards.
• Three calibration curves were prepared and analyzed by
plotting area ratios of analyte to internal standard against the
concentration of each calibration standard.
8/19/2015 Analytical Method Validation 57
58. PRECISION AND ACCURACY
• The intra-day precision and accuracy was evaluated at
three different QC levels (low, medium and high) in eight
replicates on the same day and in five replicates on three
different days for inter-day precision and accuracy
determination.
Acceptable deviation –
Within 15% of the nominal concentration for accuracy .
Within 15% relative standard deviation for precision
8/19/2015 Analytical Method Validation 58
59. PRECISION AND ACCURACY
8/19/2015 Analytical Method Validation 59
The results from intra- and inter-day precision and accuracy
indicate that the method reproducibility is acceptable within the
same day and on different days .
60. STABILITY
• The short term and long term stability of SIM and SIMA in
plasma and cell lysate samples -
• Short term stability of SIM and SIMA was evaluated in
plasma and cell lysate samples at 40C (ice-bath) for 6h.
• Long term stability of SIM and SIMA was evaluated by
storing samples for a month at -800C.
• Interconversion can be reduced either at low temperature or
when pH is adjusted between pH 4 and pH 5.tested the
stability of both SIM and SIMA in working solution kept at
-800C and they were found to be stable for at least one year .
8/19/2015 Analytical Method Validation 60
61. OUTSOURCING AGENCIES
Worldwide –
Oxford labs.
(USA , Europe)
Applus laboratories.
(china, Germany, France, Chile)
India –
India mart
(Hyderabad ,Bangluru, Pune ,Ahmadabad)
Pune-
Operon strategies, Synapse labs,Bioanalytical tech.
8/19/2015 Analytical Method Validation 61
62. REFERENCES
Tamer A.Ahmeda, Jamie Horna, John Hayslipb, Markos
Leggas, Validated LC–MS/MS method for simultaneous
determination of SIM and its acid form in human plasma and
cell lysate: Pharmacokinetic application, Journal of
Pharmaceutical Analysis, 2(2012),403-411.
Przemysław Zalewski, Judyta Cielecka-Piontek et al.,
Stability-Indicating HPLC Method for the Determination of
Cefcapene Pivoxil, Chromatographia (2013) 76:387–391.
8/19/2015 Analytical Method Validation 62
63. REFERENCES
A. Vyas, S.S. Shukla, R. Patel, R. Pandey,V. Jain, D. Singh
and B.P. Nagori, Development and Validation of
Spectrophotometric Method for Estimation of Cephalexin in
Bulk and Tablet Dosage Forms, Oriental Journal of
Chemistry,2011, Vol. 27, No. (1): Pg. 359-362.
Rebwar O. Hassan, Indirect Spectrophotometric Determination
of Cephalexin in Pharmaceutical Formulations, Chemical
Science Tran.sactions, 2013, 2(4), 1110-1117
8/19/2015 Analytical Method Validation 63
64. REFERENCES
www.fda.gov (Accessed on 11/412015)
www.ich.org (Accessed on 11/412015)
http://www.labcompliance.com/methods/meth_val.
htm#introduction. (Accessed on 11/412015)
8/19/2015 Analytical Method Validation 64